Kalbe Farma Tbk PT (KLBF) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.040x

Based on the latest financial reports, Kalbe Farma Tbk PT (KLBF) has a cash flow conversion efficiency ratio of 0.040x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp956.75 Billion ≈ $56.06 Million USD) by net assets (Rp24.19 Trillion ≈ $1.42 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See KLBF defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Kalbe Farma Tbk PT - Cash Flow Conversion Efficiency Trend (2000–2024)

This chart illustrates how Kalbe Farma Tbk PT's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Kalbe Farma Tbk PT Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Kalbe Farma Tbk PT ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Snowline Gold Corp.
V:SGD
N/A
Entra ASA
OL:ENTRA
0.054x
Syngene International Limited
NSE:SYNGENE
-0.010x
Shandong Gettop Acoustic Co Ltd
SHE:002655
-0.031x
Xiamen Leading Optics Co Ltd
SHG:605118
0.047x
Soulbrain Co. Ltd
KQ:357780
0.047x
WeRide Inc. American Depositary Shares
NASDAQ:WRD
0.022x
HCI Group Inc
NYSE:HCI
0.168x

Annual Cash Flow Conversion Efficiency for Kalbe Farma Tbk PT (2000–2024)

The table below shows the annual cash flow conversion efficiency of Kalbe Farma Tbk PT from 2000 to 2024. For the full company profile with market capitalisation and key ratios, see market value of Kalbe Farma Tbk PT.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 Rp24.59 Trillion
≈ $1.44 Billion
Rp4.79 Trillion
≈ $280.39 Million
0.195x +54.74%
2023-12-31 Rp23.12 Trillion
≈ $1.35 Billion
Rp2.91 Trillion
≈ $170.37 Million
0.126x -26.28%
2022-12-31 Rp22.10 Trillion
≈ $1.29 Billion
Rp3.77 Trillion
≈ $220.87 Million
0.171x +28.37%
2021-12-31 Rp21.27 Trillion
≈ $1.25 Billion
Rp2.83 Trillion
≈ $165.59 Million
0.133x -42.38%
2020-12-31 Rp18.28 Trillion
≈ $1.07 Billion
Rp4.21 Trillion
≈ $246.97 Million
0.231x +53.92%
2019-12-31 Rp16.71 Trillion
≈ $978.88 Million
Rp2.50 Trillion
≈ $146.66 Million
0.150x -17.30%
2018-12-31 Rp15.29 Trillion
≈ $896.20 Million
Rp2.77 Trillion
≈ $162.36 Million
0.181x +25.33%
2017-12-31 Rp13.89 Trillion
≈ $814.14 Million
Rp2.01 Trillion
≈ $117.68 Million
0.145x -16.59%
2016-12-31 Rp12.46 Trillion
≈ $730.33 Million
Rp2.16 Trillion
≈ $126.56 Million
0.173x -22.85%
2015-12-31 Rp10.94 Trillion
≈ $640.94 Million
Rp2.46 Trillion
≈ $143.97 Million
0.225x -4.79%
2014-12-31 Rp9.82 Trillion
≈ $575.27 Million
Rp2.32 Trillion
≈ $135.72 Million
0.236x +116.28%
2013-12-31 Rp8.50 Trillion
≈ $498.06 Million
Rp927.16 Billion
≈ $54.33 Million
0.109x -41.58%
2012-12-31 Rp7.37 Trillion
≈ $431.95 Million
Rp1.38 Trillion
≈ $80.65 Million
0.187x -17.44%
2011-12-31 Rp6.52 Trillion
≈ $381.81 Million
Rp1.47 Trillion
≈ $86.34 Million
0.226x +13.15%
2010-12-31 Rp5.77 Trillion
≈ $338.21 Million
Rp1.15 Trillion
≈ $67.60 Million
0.200x -29.78%
2009-12-31 Rp4.79 Trillion
≈ $280.71 Million
Rp1.36 Trillion
≈ $79.90 Million
0.285x +53.10%
2008-12-31 Rp4.34 Trillion
≈ $254.57 Million
Rp807.70 Billion
≈ $47.33 Million
0.186x +105.77%
2007-12-31 Rp4.02 Trillion
≈ $235.36 Million
Rp362.90 Billion
≈ $21.26 Million
0.090x -50.02%
2006-12-31 Rp3.54 Trillion
≈ $207.67 Million
Rp640.61 Billion
≈ $37.54 Million
0.181x +15.14%
2005-12-31 Rp2.81 Trillion
≈ $164.74 Million
Rp441.37 Billion
≈ $25.86 Million
0.157x -45.36%
2004-12-31 Rp1.48 Trillion
≈ $86.69 Million
Rp425.07 Billion
≈ $24.91 Million
0.287x -42.02%
2003-12-31 Rp1.02 Trillion
≈ $59.97 Million
Rp507.17 Billion
≈ $29.72 Million
0.496x -19.13%
2002-12-31 Rp651.41 Billion
≈ $38.17 Million
Rp399.13 Billion
≈ $23.39 Million
0.613x +25.47%
2001-12-31 Rp345.97 Billion
≈ $20.27 Million
Rp168.95 Billion
≈ $9.90 Million
0.488x +52.08%
2000-12-31 Rp305.74 Billion
≈ $17.91 Million
Rp98.17 Billion
≈ $5.75 Million
0.321x --

About Kalbe Farma Tbk PT

JK:KLBF Indonesia Drug Manufacturers - General
Market Cap
$1.96 Billion
Rp33.53 Trillion IDR
Market Cap Rank
#6399 Global
#53 in Indonesia
Share Price
Rp740.00
Change (1 day)
+0.00%
52-Week Range
Rp665.00 - Rp1595.00
All Time High
Rp2271.54
About

PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic segments. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biop… Read more